How are PMPs produced?
Advances in biotechnology have made it possible to genetically enhance plants to produce therapeutic proteins essential for the production of a wide range of pharmaceuticals – such as monoclonal antibodies, enzymes, and blood proteins. These plants are grown under highly regulated conditions in confined growing environments and are strictly regulated by the U.S. Department of Agriculture (USDA), its Animal and Plant Health Inspection Service (APHIS) and by the Food and Drug Administration (FDA).
